BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Sustained virological response
1
Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral
5/27/2022 11:37:03 AM | Browse: 266 | Download: 557
2
Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response
1/21/2022 8:16:14 AM | Browse: 349 | Download: 847
3
Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
11/20/2020 4:04:17 AM | Browse: 733 | Download: 1171
4
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
10/12/2018 5:32:21 AM | Browse: 885 | Download: 1448
5
Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review
9/27/2018 9:38:46 AM | Browse: 920 | Download: 813
6
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
3/26/2018 8:48:04 AM | Browse: 984 | Download: 1502
7
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 1195 | Download: 1646
8
Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review
1/26/2018 2:31:05 AM | Browse: 1136 | Download: 1178
9
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
1/19/2018 9:46:49 AM | Browse: 985 | Download: 882
10
Impact of sustained virologic response on chronic kidney disease progression in hepatitis C
12/27/2017 10:31:19 AM | Browse: 975 | Download: 1534
11
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 982 | Download: 1615
12
Dramatic response of hepatitis C patients chronically infected with Hepatitis C virus genotype 3 to Sofosbuvir based therapies in Punjab, Pakistan: A prospective study
11/27/2017 2:36:58 AM | Browse: 1074 | Download: 1270
13
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results
11/3/2017 6:13:02 AM | Browse: 1140 | Download: 1806
14
Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment
7/7/2017 11:41:16 AM | Browse: 930 | Download: 1505
15
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM | Browse: 1265 | Download: 1705
16
Shear wave elastography in hepatitis C patients before and after antiviral therapy
1/6/2017 8:51:00 AM | Browse: 977 | Download: 1774
17
Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12
9/14/2016 7:04:00 PM | Browse: 1108 | Download: 1730
18
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
9/4/2016 2:49:00 PM | Browse: 1265 | Download: 1606
19
Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report
7/13/2016 2:42:00 PM | Browse: 1042 | Download: 1343
20
Advances in hepatitis C therapy: What is the current state - what come's next?
1/21/2016 9:23:00 AM | Browse: 916 | Download: 1295
21
Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis
12/2/2015 12:19:00 PM | Browse: 989 | Download: 1225
22
Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3
4/14/2015 6:13:00 PM | Browse: 1067 | Download: 1523
23
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: a prospective pilot study
3/16/2015 6:04:00 PM | Browse: 986 | Download: 1121
24
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings
2/11/2015 5:56:00 PM | Browse: 1316 | Download: 1680
25
Vitamin D deficiency in chronic liver disease
12/13/2014 5:50:00 PM | Browse: 1212 | Download: 1215
26
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
11/10/2014 7:09:00 PM | Browse: 1178 | Download: 1325
27
Recurrent hepatitis C virus after transplant and the importance of plasma cells on biopsy
9/16/2014 6:58:00 PM | Browse: 1123 | Download: 681
28
Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies
9/16/2014 4:56:00 PM | Browse: 1133 | Download: 926
29
Sustained virological response: A milestone in the treatment of chronic hepatitis C
9/16/2014 11:44:00 AM | Browse: 1032 | Download: 999
30
Association between vitamin D and hepatitis C virus infection: A meta-analysis
9/12/2014 8:41:00 PM | Browse: 1264 | Download: 993
31
Interleukin 28B-related polymorphisms: A pathway for understanding hepatitis C virus infection?
9/12/2014 8:41:00 PM | Browse: 1088 | Download: 881
32
Platelet count and sustained virological response in hepatitis C treatment
9/10/2014 3:37:00 PM | Browse: 1104 | Download: 827
33
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection
9/1/2014 2:51:00 PM | Browse: 1098 | Download: 1003
34
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen
8/26/2014 2:46:00 PM | Browse: 1208 | Download: 1156
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345